Objective To study the effect of urokinase(UK) combined with liposomal alprostadil(Lipo-PG E1) in the treatment of acute myocardial infarction(AMI) and the influence of the management on the infarct-related artery(IRA) and myocardial reperfusion.

• 目的观察脂质体携载前列地尔(Lipo-PG E1)联合尿激酶(UK)治疗急性心肌梗死(AMI)对梗塞相关动脉(IRA)及心肌再灌注的作用。